What is the recommended medication for treating dyshidrotic (pompholyx) eczema in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Dyshidrotic Eczema

Start with medium to high potency topical corticosteroids applied twice daily as first-line therapy, using the least potent preparation that effectively controls symptoms. 1

First-Line Topical Treatment

Topical corticosteroids are the cornerstone of treatment:

  • Apply medium to high potency topical corticosteroids (such as betamethasone dipropionate or clobetasol propionate) twice daily for acute flares until symptoms improve 1
  • Once controlled, taper to maintenance therapy with intermittent use (twice weekly) to prevent relapses 1
  • Use the least potent preparation that effectively controls the eczema, reserving more potent formulations for limited periods only 1
  • Critical caveat: Potent and very potent topical corticosteroids carry risk of pituitary-adrenal axis suppression and should be used with caution for limited periods 1

Essential adjunctive measures:

  • Apply emollients liberally after bathing to provide a surface lipid film that retards evaporative water loss 1
  • Use dispersible cream as a soap substitute instead of regular soaps and detergents that remove natural lipids 1

Management of Acute Weeping Vesicular Lesions

For moderate cases with weeping vesicles or fissures:

  • Add potassium permanganate soaks at 1:10,000 (0.01%) concentration as antiseptic baths or compresses 2
  • This accelerates wound closure in cases with fissures 2
  • Apply particularly when vesicular lesions are weeping 2

Second-Line Treatment Options

When first-line therapy is insufficient:

  • Consider tacrolimus 0.1% ointment applied once daily to affected areas, particularly useful where prolonged steroid use is concerning 1
  • Tacrolimus provides a steroid-sparing effect and can be used for maintenance 1
  • For severe pruritus, sedating antihistamines may be useful as a short-term adjuvant during relapses 1
  • Consider ichthammol or coal tar preparations for lichenified eczema 1

Phototherapy for Refractory Disease

For severe, treatment-resistant cases:

  • Oral PUVA is the most effective phototherapy option, showing significant improvement or clearance in 81-86% of patients with hand and foot eczema 1
  • Oral PUVA has been shown superior to UVB in prospective controlled studies of hand eczema 1
  • Narrowband UVB may be considered as an alternative, showing 75% reduction in mean severity scores with 17% clearance rate 1
  • Topical PUVA has shown mixed results (58-81% improvement in uncontrolled studies) but less convincing efficacy in comparative studies 1

Management of Secondary Infection

Watch for signs of bacterial superinfection (crusting, weeping, increased redness):

  • Flucloxacillin is the first-choice antibiotic for treating Staphylococcus aureus 1
  • Use erythromycin when there is resistance to flucloxacillin or in patients with penicillin allergy 1
  • For herpes simplex virus infection (eczema herpeticum), administer acyclovir early in the course of disease 1
  • Bacteriological swabs are not routinely indicated but may be necessary if patients do not respond to treatment 1

Emerging Systemic Therapies

For severe refractory cases:

  • Methotrexate has been used for palmoplantar pompholyx, though evidence is limited to case reports 3
  • Alitretinoin has demonstrated efficacy in chronic hand dermatitis including pompholyx 4
  • Intradermal injection of botulinum toxin is an evolving treatment option 4, 5, 6
  • Novel biologic: Tralokinumab (IL-13 inhibitor) has shown success in a case report of severe dyshidrotic palmoplantar eczema, though this represents emerging evidence 7

Practical Treatment Algorithm

Mild cases with minimal vesicles:

  • Moisturizers and low-to-medium potency topical steroids 2

Moderate cases with weeping vesicles:

  • Medium to high potency topical steroids twice daily PLUS potassium permanganate soaks at 1:10,000 concentration 1, 2

Severe or refractory cases:

  • Continue topical therapy AND add oral PUVA as the most effective phototherapy option 1
  • Consider systemic immunosuppressants or alitretinoin for recalcitrant disease 4

Important Caveats

  • Avoid extremes of temperature and irritant clothing, and keep nails short to minimize trauma and secondary infection risk 1
  • Combination therapy with antibiotics and steroids has not shown additional benefit compared to steroids alone 1
  • In practice, patients benefit most from a combination of treatments rather than monotherapy 4

References

Guideline

Treatment of Dyshidrotic Eczema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Potassium Permanganate Solution for Dyshidrotic Eczema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pompholyx: what's new?

Expert opinion on investigational drugs, 2008

Research

Pharmacotherapy of pompholyx.

Expert opinion on pharmacotherapy, 2004

Research

Successful treatment of dyshidrotic palmoplantar eczema with tralokinumab.

The Australasian journal of dermatology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.